Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The occurrence of cystic acne is encouraged with the aid of demographic elements, with teenagers and teenagers being more prone. Hormonal changes in the course of puberty contribute to the development of cystic acne, shaping the market for zits-related merchandise and remedies targeted at this age group. Genetic factors play a function in the development of cystic acne. Individuals with their family records of intense pimples may be more vulnerable to experiencing cystic acne. This genetic predisposition influences the demand for centered treatments and skin care products in affected populations. Hormonal imbalances, mainly growth in androgens, are a big aspect in the development of cystic acne. Hormonal modifications all through the menstrual cycle, pregnancy, or situations like polycystic ovary syndrome (PCOS) can contribute to zits flare-ups, impacting the market for hormone-regulating zits treatments.
Environmental elements, including pollutants and exposure to certain chemicals, can exacerbate cystic acne. The market responds to the demand for skin care merchandise that copes with environmental stressors and offers shielding measures against pimple triggers. Dietary habits and way of life selections, together with excessive glycemic diets and sure dairy merchandise, have been linked to the development of zits. Consumer awareness of the connection between weight loss plans and cystic acne influences market developments, with a demand for skin care products and dietary supplements targeting pimples-inclined people. Ongoing research and development in dermatology make contributions to the evolution of cystic acne treatments. The market is aware of innovations in topical and systemic treatments, which include novel components, formulations, and shipping techniques aimed toward improving efficacy and decreasing side consequences.
Public focus campaigns and educational efforts affect the cystic acne market. Informative tasks, approximately proper skincare practices, early intervention, and available remedy alternatives contribute to modifications in customer conduct, influencing the demand for dermatological consultations and products. The psychosocial impact of cystic acne, inclusive of its impact on shallowness and intellectual well-being, is a big market aspect. Skincare and beauty products addressing the emotional aspects of zits, in addition to mental health help, contribute to the holistic control of cystic acne. Social media structures play a function in shaping beauty standards and influencing purchaser choices. Trends in skin care routines, product suggestions, and achievement stories shared on social media impact the market for cystic acne merchandise, riding client options, and purchasing selections. The volume of medical health insurance insurance for acne-associated treatments influences patients' right of entry to to prescription medicines and dermatological offerings.
Covered Aspects:
| Report Attribute/Metric | Details |
|---|---|
| Growth Rate | Â Â 8.4% |
Cystic Acne Market Highlights:
Cystic Acne Market Overview
Cystic Acne Market Size was valued at USD 7.36 Billion in 2023. The Cystic Acne industry is projected to grow from USD 7.97 Billion in 2024 to USD 14.98 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 9.01% during the forecast period (2024 - 2032).
Cystic acne is the most serious type of acne, it is the type of skin condition wherein the pores of the skin get blocked, which leads to infection or inflammation of the affected area of the skin. Sometimes bacteria get trapped inside the pore and swell the infected skin area. It happens when the infection went deep into the skin and spread throughout the body. Although bacterium (P. acne bacteria) causes the cystic acne, which also causes papules, pustules, and such others, Cystic acne lesions are one of the most difficult acne to treat. These lesions are more painful and have a risk of scarring the skin and causing a permanent damage as compared to mild or moderate acne.
According to the American Academy of Dermatology Association, around 50 million Americans get affected annually with acne, and it is the most common skin condition in the Americas. Additionally, approximately 85% of people between the ages of 12 and 24 experience at least minor acne.
Rising prevalence of this conditions both in developed and developing countries is driving the cystic acne market growth. The skin care industry and research laboratories are involved in research and development to provide the better treatment. According to Leon H. Kircik, M.D., clinical associate professor of dermatology at Indiana University School of Medicine, recent research on severe and moderate acne patients with inflammatory acne helps to confirm the strength and efficacy of fixed-dose combination gel adapalene/benzoyl peroxide 0.3%/2.5%.
The factors that cause cystic acne are too much oil production in the glands of the skin and growth of the bacteria called Propionibacterium acnes. Moreover, advancing technology in healthcare is adding fuel to the growth of the market. However, effective treatments are not available in the market, which may hamper the market growth during the forecast period.
Intended Audience
- Research and Development (R&D) Companies
- Government Research Laboratories
- Independent Research Laboratories
- Government and Independent Regulatory Authorities
- Market Research and Consulting Service Providers
- Medical Research Laboratories
- Academic Medical Institutes and Universities
Figure: Global Cystic acne Market, By Region Market Share, 2016 (%) 
Sources: Annual reports, Press release, White paper, Company presentation
Cystic Acne Market Segment Insights
The global cystic acne market is segmented on the basis of causes, long-term effects, treatment type, and end user.
On the basis of the causes, it is segmented into hormonal imbalances, occlusive skin products, drugs/chemical side effects, and others.
On the basis of the long-term effects, it is segmented into ice pick scars, larger pits on the skin, shallow depressions, hypertrophic scarring, and others.
On the basis of the treatment type, it is segmented into topical medications, drainage & extraction procedure, laser therapy, microdermabrasion, and others.
On the basis of the end user, it is segmented into hospitals, clinics, research laboratories, and others.
Cystic Acne Market Regional Analysis
The Americas dominate the global cystic acne market owing to well-developed technology and increasing population with acne. Key players are focusing on capturing maximum share of the emerging markets such as India and China. According to American Academy of Dermatology Association, in 2016 the costs associated with the treatment of acne exceed USD 3 billion.
Europe holds the second position in the global cystic acne market owing to the government support for research & development and availability of funds for research. This is expected to drive the European cystic acne market over the forecasted period.
The Asia Pacific is the fastest growing cystic acne market owing to the presence of rapidly growing patient population, and high healthcare expenditure. The government of this region focuses more on providing better treatment to the citizen of their countries for improving their quality of life.
On the other hand, in the Middle East and Africa, cystic acne has become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment.
Cystic Acne Market- Key Players
Some of the key players in this cystic acne market are
- GlaxoSmithKline plc (U.K)
- Pfizer Inc. (U.S.)
- Abbott Laboratories (U.S.)
- Hexal AG (Germany)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Alma Lasers Inc. (Israel)
- Bristol-Myers Squibb Company (U.S.)
- GE Healthcare (U.K)
- National Biological Corp. (U.S.)
- Herbert Waldmann GmbH & Co. KG (Germany)
- Sylvan Company (U.S.)
- DUSA Pharmaceuticals Inc. (U.S.)
Research Methodology
Sources: Annual reports, Press release, White paper, and Company presentation
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
